In Gucci v. Agfa (21 October 2026, UPC_CoA_582/2025), Agfa sued Gucci for infringement of its patent EP 3 388 490, covering a method for decorating natural leather. Gucci challenged the patent’s validity, relying on some of their leather articles marketed before Agfa’s patent filing date. Gucci submitted chemical analyses of these articles showing that the claimed process features, namely the use of UV-curable pigmented inks and an achromatic base coat, could have been identified before the filing date. Importantly, the analytical techniques used were known and available at the patent filing date.
In 2025, the Hamburg Local Division had dismissed both actions, on novelty, finding that Gucci’s earlier products did not anticipate the patent because their ivory-colored base coat, containing chromatic pigments, fell outside the claimed “achromatic” color. The Court of Appeal disagreed. Relying on the patent description, which expressly included off-white shades and mixtures of chromatic and achromatic pigments as embodiments of the invention, the Court held that what matters was the resulting color of the base coat, rather than the mere presence of chromatic pigments. The Court therefore found that Gucci’s earlier marketed products satisfied the “achromatic color” requirement.
The Court further clarified that:
- A manufacturing process forms part of the prior art if its claimed features could have been identified by analyzing a publicly available product without undue burden.
- No particular motivation to analyze the product is required.
- The disclosure should only enable the skilled person to carry out the claimed process, without necessarily reproducing all the characteristics of the marketed product (in this case, the exact ink formulation).
These principles led the Court to find the process and product claims invalid. However, some process claims were maintained in a limited form (claim 5, reciting that the ink should include polyfunctional monomers or oligomers in a particular concentration). Agfa’s infringement action nevertheless failed, because Agfa failed to show that Gucci’s ink reproduced the features of claim 5. Reversing the burden of proof under Article 55 UPCA was not possible, according to the Court, because the claimed process does not lead to a new product.
Key takeaway: In line with EPO decisions G 1/92 and G 1/23, the UPC confirms that an earlier marketed product may anticipate a patented manufacturing process, even if its exact manufacturing process was never publicly disclosed. This judgment also highlights the importance for a Patentee of securing evidence of process features before bringing an infringement action.
November 2026